13F filer · CIK 1065521 ↗
SoftBank Group
You are looking at Q4 2025. See the latest, Q2 2026 →
Reported value
$15.47B
−40% on the quarter before
Positions
32
5 new · 2 sold out
Top 10
95.3%
of the value
Est. gain
−$944.7M
on stocks held all quarter
Est. return
−6.1%
on those stocks since Q3 2025
Positions as of Dec 31, 2025, from SoftBank Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2025. Striped tiles are options.
Largest buys
Since Q3 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Twenty One Cap Inc~$780.6MNew · 0.0% → 5.0%+89,106,748 shares
- Etoro Group Ltd~$14.0MAdded · 0.1% → 0.2%+397,998 shares
- Circle~$7.6MNew · 0.0% → 0.0%+95,659 shares
- Uber~$1.5MNew · 0.0% → 0.0%+18,497 shares
- Abcellera Biologics Inc~$1.2MNew · 0.0% → 0.0%+345,161 shares
- Coinbase~$263,001New · 0.0% → 0.0%+1,163 shares
Largest sells
Since Q3 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Nvidia~$5.99BSold out · 23.1% → 0.0%−32,110,456 shares
- T-Mobile Us~$3.38BCut · 41.6% → 37.4%−16,671,036 shares
- Metsera Inc~$191.2MSold out · 0.7% → 0.0%−3,654,691 shares
- Lemonade~$187.8MCut · 0.7% → 0.4%−2,638,428 shares
- Inter & Co I~$33.9MCut · 2.3% → 3.3%−4,000,000 shares
- Full Truck Alliance Co Ltd~$5.6MCut · 0.2% → 0.3%−521,828 shares
- Recursion Pharmaceuticals In~$4.2MCut · 0.3% → 0.4%−1,030,976 shares
- Neumora Therapeutics Inc.~$199,531Cut · 0.0% → 0.1%−111,470 shares
Holdings
As of Dec 31, 2025. Changes are in shares against Sep 30, 2025, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| T-Mobile UsCOM · shares −37% · price −15.2% | 37.4% | $5.79B | −$1.04B | ||||||||
| IntelCOM · shares 0% · price +10.0% | 20.7% | $3.21B | +$291.3M | ||||||||
| SymboticCLASS A COM · shares 0% · price +10.4% | 15.3% | $2.37B | +$223.0M | ||||||||
| Twenty One Cap IncCOM SHS CL A · shares New | 5.0% | $780.6M | — | ||||||||
| TSMCSPONSORED ADS · shares 0% · price +8.8% | 3.9% | $603.2M | +$48.8M | ||||||||
| Inter & Co ICLASS A CO · shares −6.2% · price −8.1% | 3.3% | $513.1M | −$45.4M | ||||||||
| Klarna Group PlcSHS · shares 0% · price −21.1% | 2.9% | $445.2M | −$119.2M | ||||||||
| Webtoon Entmt IncCOM · shares 0% · price −32.9% | 2.6% | $409.6M | −$200.5M | ||||||||
| Tempus AICL A · shares 0% · price −26.8% | 2.1% | $319.2M | −$117.1M | ||||||||
| Nu Hldgs LORD SHS CL · shares 0% · price +4.6% | 1.9% | $298.7M | +$13.0M | ||||||||
| VtexSHS CL A · shares 0% · price −14.2% | 0.93% | $144.5M | −$23.8M | ||||||||
| Chime Finl IncCOM SHS CL A · shares 0% · price +24.8% | 0.82% | $127.5M | +$25.3M | ||||||||
| Qxo IncCOM NEW · shares 0% · price +1.2% | 0.68% | $105.5M | +$1.3M | ||||||||
| LemonadeCOM · shares −74% · price +33.0% | 0.43% | $65.9M | +$16.3M | ||||||||
| Recursion Pharmaceuticals InCL A · shares −7.0% · price −16.2% | 0.36% | $55.8M | −$10.8M | ||||||||
| Full Truck Alliance Co LtdSPONSORED ADS · shares −12% · price −17.3% | 0.27% | $41.7M | −$8.7M | ||||||||
| Pacific Biosciences Calif InCOM · shares 0% · price +46.1% | 0.25% | $38.2M | +$12.1M | ||||||||
| Afya LtdCL A COM · shares 0% · price −1.2% | 0.24% | $37.5M | −$462,332 | ||||||||
| Etoro Group LtdSHS CL A · shares +100% · price −14.9% | 0.18% | $28.0M | −$2.4M | ||||||||
| Better Home & Finance HoldinCOM NEW CL A · shares 0% · price −42.0% | 0.13% | $20.5M | −$14.8M | ||||||||
| Globalstar IncCOM · shares 0% · price +67.7% | 0.13% | $19.6M | +$7.9M | ||||||||
| Neumora Therapeutics Inc.COM · shares −1.7% · price −1.6% | 0.07% | $11.5M | −$192,892 | ||||||||
| Seer IncCOM CL A · shares 0% · price −15.7% | 0.06% | $9.4M | −$1.7M | ||||||||
| CircleCOM CL A · shares New | 0.05% | $7.6M | — | ||||||||
| SatellogicCOM CL A · shares 0% · price −43.0% | 0.03% | $4.8M | −$3.6M | ||||||||
| Total · 32 positions | 100% | $15.47B | −$944.7M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2025 to Q4 2025: 27 stocks held throughout, down $944.7M (−6.1%).
- Intel+$291.3M+10%
- Symbotic+$223.0M+10%
- TSMC+$48.8M+9%
- Chime Finl Inc+$25.3M+25%
- Lemonade+$16.3M+33%
- Inter & Co I−$45.4M−8%
- Tempus AI−$117.1M−27%
- Klarna Group Plc−$119.2M−21%
- Webtoon Entmt Inc−$200.5M−33%
- T-Mobile Us−$1.04B−15%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $18.17B+59% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $11.41B−26% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $15.47B−40% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $25.97B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $24.94B−15% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $29.31B+25% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $23.37B+6% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $21.95B−44% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 (amended) | $39.11B+105% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $19.06B+3% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $18.54B+6% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $17.56B+97% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $8.92B+15% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $7.76B+16% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $6.66B−1% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $6.76B−14% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $7.83B−22% | SEC ↗ |
| Q1 2022 | Sep 21, 2022 (amended) | $9.99B−7% | SEC ↗ |
| Q4 2021 | Sep 21, 2022 (amended) | $10.75B−5% | SEC ↗ |
| Q3 2021 | Feb 22, 2022 (amended) | $11.26B−42% | SEC ↗ |
| Q2 2021 | Nov 15, 2021 (amended) | $19.33B+33% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $14.58B−9% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $15.95B+23% | SEC ↗ |
| Q3 2020 | Nov 12, 2020 | $12.92B−26% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $17.52B−41% | SEC ↗ |
| Q1 2020 | Oct 2, 2020 | $29.70B+65% | SEC ↗ |
| Q4 2019 | Oct 2, 2020 | $17.95B−16% | SEC ↗ |
| Q3 2019 | Oct 9, 2020 | $21.26B−6% | SEC ↗ |
| Q2 2019 | Oct 9, 2020 | $22.64B+16% | SEC ↗ |
| Q1 2019 | Oct 9, 2020 | $19.49B−3% | SEC ↗ |
| Q4 2018 | Oct 9, 2020 | $20.15B−11% | SEC ↗ |
| Q3 2018 | Oct 16, 2020 | $22.56B+21% | SEC ↗ |
| Q2 2018 | Oct 16, 2020 | $18.60B+11% | SEC ↗ |
| Q1 2018 | Oct 16, 2020 | $16.68B−16% | SEC ↗ |
| Q4 2017 | Oct 16, 2020 | $19.96B−23% | SEC ↗ |
| Q3 2017 | Oct 23, 2020 | $25.91B−17% | SEC ↗ |
| Q2 2017 | Oct 23, 2020 | $31.25B−2% | SEC ↗ |
| Q1 2017 | Oct 23, 2020 | $31.73B+3% | SEC ↗ |
| Q4 2016 | Oct 23, 2020 | $30.81B+40% | SEC ↗ |
| Q3 2016 | Oct 30, 2020 | $22.02B+45% | SEC ↗ |
| Q2 2016 | Oct 30, 2020 | $15.17B+30% | SEC ↗ |
| Q1 2016 | Oct 30, 2020 | $11.69B | SEC ↗ |